Grupo de Investigación Pharmananogene

• Gómez-Aguado I, Rodríguez-Castejón J, Vicente-Pascual M, Rodríguez-Gascón A, Pozo-Rodríguez AD, Solinís Aspiazu MÁ  Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA Molecules,  2020;  25
• Gómez-Aguado I, Rodríguez-Castejón J, Vicente-Pascual M, Rodríguez-Gascón A, Solinís MÁ, Del Pozo-Rodríguez A  Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives Nanomaterials (Basel),  2020;  10
• Ibar-Bariain M, Rodríguez-Gascón A, Isla A, Solinís MÁ, Canut-Blasco A  Evaluation of the adequacy of the antimicrobial therapy of invasive Haemophilus influenzae infections: A pharmacokinetic/pharmacodynamic perspective Enfermedades Infecciosas y Microbiología Clínica,  2020;  39,  65 - 71
• Vicente-Pascual M, Gómez-Aguado I, Rodríguez-Castejón J, Rodríguez-Gascón A, Muntoni E, Battaglia L, Del Pozo-Rodríguez A, Solinís Aspiazu MÁ  Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production Pharmaceutics,  2020;  12
• Barrasa H, Soraluce A, Usón E, Sainz J, Martín A, Sánchez-Izquierdo JÁ, Maynar J, Rodríguez-Gascón A, Isla A.  Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective International Journal of Infectious Diseases,  2020;  93,  329 - 338
• Rodríguez-Gascón A, Aguirre-Quiñonero A, Canut-Blasco A  Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective Enfermedades Infecciosas y Microbiología Clínica,  2020;  38,  306 - 311
• Soraluce A, Barrasa H, Asín-Prieto E, Sánchez-Izquierdo JÁ, Maynar J, Isla A, Rodríguez-Gascón A  Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation Pharmaceutics,  2020;  12
• del Pozo-Rodríguez A, Rodríguez-Gascón A, Rodríguez-Castejón J, Vicente-Pascual M, Gómez-Aguado I, Battaglia LS, Solinís MÁ  Gene Therapy Advances in Biochemical Engineering / Biotechnology,  2020;  171,  321 - 368
• Lertxundi Etxebarria U, Palacios-Zabalza I, Ibarrondo I, Domingo-Echaburu S, Hernandez R, Isla A, Solinis M.  Pharmacotherapeutic management of Parkinson's disease inpatients: how about asking hospital pharmacists? European Journal of Hospital Pharmacy,  2020;  2020
• Oñatibia-Astibia A, Malet-Larrea A, Gastelurrutia MÁ, Calvo B, Ramírez D, Cantero I, Goyenechea E.  Effect of health professional intervention on adherence to statin use according to the cause of patient non-adherence. International Journal of Clinical Pharmacy,  2020;  42,  331 - 335
• Oñatibia-Astibia A, Malet-Larrea A, Gastelurrutia MÁ, Calvo B, Goyenechea E.  Community pharmacist interventions to improve adherence to lipid lowering medication and their influence on clinical outcomes: A systematic review and meta-analysis Journal of Evaluation on Clinical Practice,  2020